{{'Wed, 30 Oct 2024 17:00:00 -0400' | dateFormatUsFilter}}
STEP 9 results, published in NEJM, demonstrated semaglutide reduced knee osteoarthritis-related pain in people with obesity
Read more
{{'Wed, 23 Oct 2024 13:15:00 -0400' | dateFormatUsFilter}}
Novo Nordisk to present new cardiometabolic and renal data, including with semaglutide, at Kidney Week 2024, ObesityWeek®, The Liver Meeting®, and AHA Scientific Sessions 2024
Read more
{{'Fri, 06 Sep 2024 12:59:00 -0400' | dateFormatUsFilter}}
Novo Nordisk to present new data from key diabetes and obesity trials at the 60th Annual Meeting of the European Association for the Study of Diabetes
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.